Inflarx Nv Stock Alpha and Beta Analysis
| IFRX Stock | USD 2.33 0.22 8.63% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as InflaRx NV. It also helps investors analyze the systematic and unsystematic risks associated with investing in InflaRx NV over a specified time horizon. Remember, high InflaRx NV's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to InflaRx NV's market risk premium analysis include:
Beta 0.46 | Alpha 0.82 | Risk 5.32 | Sharpe Ratio 0.16 | Expected Return 0.84 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
InflaRx |
InflaRx NV Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. InflaRx NV market risk premium is the additional return an investor will receive from holding InflaRx NV long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in InflaRx NV. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate InflaRx NV's performance over market.| α | 0.82 | β | 0.46 |
InflaRx NV expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of InflaRx NV's Buy-and-hold return. Our buy-and-hold chart shows how InflaRx NV performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.InflaRx NV Market Price Analysis
Market price analysis indicators help investors to evaluate how InflaRx NV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading InflaRx NV shares will generate the highest return on investment. By understating and applying InflaRx NV stock market price indicators, traders can identify InflaRx NV position entry and exit signals to maximize returns.
InflaRx NV Return and Market Media
The median price of InflaRx NV for the period between Fri, Oct 11, 2024 and Thu, Jan 9, 2025 is 2.12 with a coefficient of variation of 20.54. The daily time series for the period is distributed with a sample standard deviation of 0.42, arithmetic mean of 2.02, and mean deviation of 0.38. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About InflaRx NV Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including InflaRx or other stocks. Alpha measures the amount that position in InflaRx NV has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
InflaRx NV Upcoming Company Events
As portrayed in its financial statements, the presentation of InflaRx NV's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, InflaRx NV's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of InflaRx NV's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of InflaRx NV. Please utilize our Beneish M Score to check the likelihood of InflaRx NV's management manipulating its earnings.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with InflaRx NV
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.